BSE filing, NSE: SANOFI. Summary written from the filing by ALFA Finder's alert engine.
Sanofi India Ltd: key numbers
- Share price
- ₹3,283.10
- Market cap
- ₹7,561 Cr
- Revenue (annual)
- ₹1,837 Cr
- Net profit (annual)
- ₹326.7 Cr
- P/E (TTM)
- 20.7×Sector 43.0×
- Promoter holding
- 60.40%+0.00% QoQ
- FII holding
- 5.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanofi India Ltd
All →Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Sanofi India Dividend
Sanofi India declared an interim dividend of Rs 75 per equity share at its 29-Oct-2026 board meeting. Record date is 5-Nov-2026.
Sanofi India Q2 FY27 Results: Net Profit ₹116.7 Cr, Up 53.6% YoY
Sanofi India reported unaudited Q3 and nine-month results to 30 September 2026, with profit before tax up 22% to INR 158 crore. It also declared an interim dividend of Rs 75 per share with a record date of 5 November 2026.
- Key figure
- Net profit ₹116.7 Cr · +53.6% YoY
Sanofi India Other Announcement
Sanofi India Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Sanofi India Board Meeting Date
Sanofi India will hold a board meeting on 29th October 2026 to consider unaudited financial results and a potential interim dividend for FY 2026.
Sanofi India Promoter Buying (Off-Market): ₹1,068 Cr
Sanofi Healthcare India acquired 3.5 million shares (15.20%) from Hoechst GmbH in a promoter-group block deal at ₹3,052/share. Total promoter stake unchanged at 60.40%.
- Value
- ₹1,068 Cr
- Promoter stake change
- +15.20%
Other board meeting outcome announcements
All →Chatterbox Technologies Board Meeting Outcome
Chatterbox's board approved a Rs. 7 crore related-party ceiling with its UAE subsidiary and a vendor change for IPO funds. Monitoring agency and deviation reports were also noted.
BCC Fuba India Board Meeting Outcome
BCC Fuba India's board met on November 6, 2026 and took note of consolidated related party transactions for the half year ended September 30, 2026. No financial results, capital raise or other material decision was reported.
Voltas Board Meeting Outcome
Voltas Limited's board approved Deloitte Haskins & Sells as statutory auditors for five years from the 73rd AGM, replacing SRBC & Co. LLP, whose second and final term ends at that AGM. Subject to shareholder approval.
- Execution
- Five years: financial years 2027-28 to 2031-32 (from the 73rd AGM in 2027 to the 78th AGM in 2032)
CMX Holdings Board Meeting Outcome
Riwind Green Energy (formerly CMX Holdings) board approved altering its MOA main objects into six consolidated objects and a postal ballot notice. The change refocuses the company on solar, EPC, battery storage and renewable data-centre businesses.
Sahajanand Medical Technologies Board Meeting Outcome
Sahajanand Medical Technologies' board appointed M/s Amit Jaste & Associates as Secretarial Auditor for FY 2026-27 to FY 2030-31. The appointment is subject to shareholder approval.
- Execution
- FY 2026-27 to FY 2030-31, five consecutive financial years, subject to shareholder approval
Gretex Corporate Services Board Meeting Outcome
Gretex Corporate Services re-appointed Arvind Harlalka, Alok Harlalka and Rajiv Kumar Agarwal as directors after a board meeting. Terms are 60 months, effective from April 2027 and May 2027.
- Execution
- 60 months